Trial Profile
A Phase I/IIb Randomized, Double-blind, Controlled Study of the Safety, Immunogenicity and Proof-of-concept of RTS,S/AS02D, a Candidate Malaria Vaccine in Infants Living in a Malaria-endemic Region
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs GSK 257049 (Primary) ; AS02; Hepatitis B vaccine recombinant; Hib-DTP vaccine
- Indications Malaria
- Focus Adverse reactions
- Sponsors GSK
- 28 Jan 2008 Status change from in progress to completed.
- 14 Nov 2006 Status change
- 12 Dec 2005 New trial record.